Hold on a moment. This sounds like re-cycled old news? The whole...

Hold on a moment. This sounds like re-cycled old news? The whole thing sounds exactly the same like before. The only change is "will" to "has released".

Zero detail of clinical trial plan and zero detail for marketing & sales and zero detail of projected revenue. This is exactly what I expected based on what they trickled out before. I was hoping that they named their partners for clinical trials as they were going to outsource.

Will see how this impact the share price. Probably a slight pop then a drop again.

I see it resumes trading. Up 1c. Not the 50% pop I was hoping to see.